• Erastin as a Ferroptosis Inducer: Advanced Protocols & Insig

  2026-05-25

  Erastin stands as the gold-standard ferroptosis inducer, enabling researchers to dissect oxidative vulnerabilities in RAS/BRAF-mutant tumor models and optimize immunotherapy strategies. This article delivers actionable protocols, troubleshooting guidance, and a translational readout of the latest findings linking ferroptosis to enhanced anti-tumor immunity.

• Apicidin: Histone Deacetylase Inhibitor for Precision Epigen

  2026-05-24

  Apicidin empowers researchers to dissect chromatin regulation with high selectivity, enabling robust modeling of anti-proliferative and anti-angiogenic mechanisms in cancer and reproductive biology. This guide delivers stepwise workflows, troubleshooting strategies, and actionable insights drawn from pioneering studies and product best practices.

• Patient-Derived Glioma Organoids Preserve Tumor Microenviron

  2026-05-23

  This study introduces a glioma organoid model that retains the original tumor microenvironment, including resident immune cells, enabling more accurate drug screening and therapeutic evaluation. The approach addresses a long-standing limitation in glioma research by preserving molecular and cellular features of patient tumors ex vivo.

• Oligo (dT) 25 Beads: Technical Guide for Eukaryotic mRNA Iso

  2026-05-22

  Oligo (dT) 25 Beads enable rapid, high-purity eukaryotic mRNA isolation from total RNA or cell/tissue lysates, supporting downstream applications such as RT-PCR and next-generation sequencing. They are optimal for workflows requiring specific capture of polyA-tailed transcripts; however, they are not designed for non-eukaryotic or non-polyadenylated RNA targets.

• BKT140 (BL-8040) CXCR4 Antagonist: Precision Oncology Workfl

  2026-05-22

  BKT140 (BL-8040) empowers researchers to dissect CXCR4-mediated tumor dynamics and optimize hematopoietic stem cell mobilization in translational oncology settings. Discover protocol-driven workflows, troubleshooting insights, and data-backed advantages that position this antagonist as an essential tool for high-impact cancer research.

• Polysialylated CD56–Siglec-7 Axis Drives Immune Evasion in c

  2026-05-21

  This study identifies polysialylated CD56 (PSA-CD56) as a key glycan immune checkpoint mediating immune evasion in clear cell renal cell carcinoma (ccRCC) by engaging Siglec-7 on CD8 T cells. The findings reveal that targeting the PSA-CD56/Siglec-7 axis restores T cell function and enhances tumor cell apoptosis, offering promising new avenues for overcoming immunotherapy resistance.

• SEMA3E Drives Beige Adipocyte Thermogenesis via β-Catenin

  2026-05-21

  This study uncovers SEMA3E as a critical regulator of beige adipocyte differentiation and thermogenesis in mice, acting through β-catenin signaling. The findings expand mechanistic insights into adipose tissue plasticity, suggesting new targets for metabolic disease research.

• 4-Hydroxytamoxifen: Technical Guidance for Laboratory Protoc

  2026-05-20

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator optimized for laboratory protocols in breast cancer, prostate cancer, and cardiac myocyte research. It is ideal for workflows requiring DMSO solubility and strict storage conditions but unsuitable for aqueous or ethanol-based applications.

• L. gasseri ATCC33323 Modulates Colitis via NR1I3-E-cadherin

  2026-05-20

  This study uncovers how Lactobacillus gasseri ATCC33323 ameliorates DSS-induced colitis by regulating the intestinal mucosal barrier. The probiotic exerts its therapeutic effect through an NR1I3-mediated increase in E-cadherin expression, highlighting a novel mechanism for microbiota-driven protection against inflammatory bowel disease.

• Red Blood Cell Lysis Buffer: Optimizing Erythrocyte Removal

  2026-05-19

  APExBIO’s Red Blood Cell Lysis Buffer empowers researchers to achieve efficient and selective erythrocyte removal, preserving critical nucleated cells for sensitive downstream applications. This guide bridges cutting-edge protocol insights, troubleshooting strategies, and translational findings to maximize the buffer’s potential in hematology, immunology, and osteoblastic research.

• Clozapine in Schizophrenia Research: Protocols & Innovations

  2026-05-19

  Clozapine stands apart as an atypical antipsychotic medication for modeling treatment-resistant schizophrenia, thanks to its unique receptor profile and ERK1/2 signaling activation. This guide delivers actionable workflows, troubleshooting strategies, and protocol enhancements for maximizing the impact of APExBIO’s Clozapine in advanced translational neuroscience.

• Mechanistic Precision in mRNA Purification: Strategic Levera

  2026-05-18

  This thought-leadership article examines how advanced mechanistic understanding of mRNA purification—anchored by Oligo (dT) 25 Beads—empowers translational researchers to decode complex regulatory axes in cancer and beyond. Integrating recent discoveries on epigenetic-metabolic crosstalk and referencing evolving best practices in magnetic bead-based mRNA isolation, the piece provides actionable guidance on experimental design, workflow optimization, and the translational impact of high-fidelity eukaryotic mRNA isolation.

• Reliable Native Protein Gel Electrophoresis: Kit PI ≤ 7.0 (K

  2026-05-18

  This article guides biomedical researchers and lab technicians through real laboratory scenarios where the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0), SKU K4142, addresses common challenges in native protein gel electrophoresis. By emphasizing practical workflow decisions and referencing quantitative data, we demonstrate how this kit supports reproducible, biologically relevant protein analysis. Direct links to protocols and peer-reviewed studies offer immediate, actionable value.

• N3-kethoxal: Precision Probe for RNA & Accessible DNA Mappin

  2026-05-17

  N3-kethoxal is a membrane-permeable, azide-functionalized nucleic acid probe enabling selective covalent labeling of unpaired guanine bases. It empowers high-resolution RNA secondary structure probing, genomic mapping of accessible DNA, and advanced bioorthogonal click chemistry workflows in both in vitro and in vivo contexts.

• CX-5461: RNA Polymerase I Inhibitor for Solid Tumor Research

  2026-05-16

  CX-5461 is a potent, orally bioavailable RNA polymerase I inhibitor, enabling selective blockade of ribosome biogenesis in solid tumors. This guide translates recent mechanistic breakthroughs—like mitotic catastrophe induction in cervical cancer—into actionable protocols and troubleshooting tips for advanced cancer research.

404 records 7/27 page Previous Next First page 上5页 678910 下5页 Last page